ViaCyte Interview on Diabetes Stem Cell Trials & Cool Role of Gore-Tex Tech
When I think of the promise of stem cells for diabetes, the privately held California stem cell firm ViaCyte is the first biotech that comes to mind now. It has promising stem cell clinical trial work...
View ArticleGreat News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product
Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the...
View ArticleDiabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient
Chalk up another exciting development for the stem cell and regenerative medicine field in 2014 related to diabetes. It’s been a huge year. (Update: read my Fall 2019 interview with ViaCyte here.) For...
View ArticleViaCyte CEO Laikind Interview: Trial Update, Melton, & Future
It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte....
View ArticleViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP
Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have...
View Article
